المؤلفون: Walk, Seth T., Micic, Dejan, Galecki, Andrzej T., Young, Vincent B., Aronoff, David M.

المصدر: Clinical Infectious Diseases, 2013 Aug . 57(4), 625-626.

الوصول الحر: http://dx.doi.org/10.1093/cid/cit310Test

المؤلفون: Walk, Seth T., Micic, Dejan, Galecki, Andrzej T., Rogers, Mary A. M., Washer, Laraine, Newton, Duane W., Malani, Preeti N., Young, Vincent B., Aronoff, David M.

المصدر: Clinical Infectious Diseases, 2013 Jun . 56(12), 1846-1847.

الوصول الحر: http://dx.doi.org/10.1093/cid/cit099Test

المؤلفون: Walk, Seth T., Micic, Dejan, Jain, Ruchika, Lo, Eugene S., Trivedi, Itishree, Liu, Eugene W., Almassalha, Luay M., Ewing, Sarah A., Ring, Cathrin, Galecki, Andrzej T., Rogers, Mary A. M., Washer, Laraine, Newton, Duane W., Malani, Preeti N., Young, Vincent B., Aronoff, David M.

المصدر: Clinical Infectious Diseases, 2012 Dec . 55(12), 1661-1668.

الوصول الحر: http://dx.doi.org/10.1093/cid/cis786Test

المؤلفون: Rao, Krishna, Micic, Dejan, Chenoweth, Elizabeth, Deng, Lili, Galecki, Andrzej T., Ring, Cathrin, Young, Vincent B., Aronoff, David M., Malani, Preeti N.

مصطلحات موضوعية: geriatric, aging, Clostridium difficile, colitis, infection, Geriatrics, Health Sciences

وصف الملف: application/pdf

العلاقة: Rao, Krishna; Micic, Dejan; Chenoweth, Elizabeth; Deng, Lili; Galecki, Andrzej T.; Ring, Cathrin; Young, Vincent B.; Aronoff, David M.; Malani, Preeti N. (2013). "Poor Functional Status as a Risk Factor for Severe Clostridium difficile Infection in Hospitalized Older Adults." Journal of the American Geriatrics Society 61(10): 1738-1742.; http://hdl.handle.net/2027.42/112304Test; Journal of the American Geriatrics Society; Cohen SH, Gerding DN, Johnson S et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431 – 455.; Bartlett JG. Antibiotic‐associated diarrhea. N Engl J Med 2002; 346: 334 – 339.; Lima AA, Innes DJ Jr, Chadee K et al. Clostridium difficile toxin A. Interactions with mucus and early sequential histopathologic effects in rabbit small intestine. Lab Invest 1989; 61: 419 – 425.; Hecht G, Koutsouris A, Pothoulakis C et al. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology 1992; 102: 416 – 423.; Brito GA, Sullivan GW, Ciesla WP Jr et al. Clostridium difficile toxin A alters in vitro‐adherent neutrophil morphology and function. J Infect Dis 2002; 185: 1297 – 1306.; Akerlund T, Svenungsson B, Lagergren A et al. Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile ‐associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. J Clin Microbiol 2006; 44: 353 – 358.; Henrich TJ, Krakower D, Bitton A et al. Clinical risk factors for severe Clostridium difficile ‐associated disease. Emerg Infect Dis 2009; 15: 415 – 422.; Kyne L, Sougioultzis S, McFarland LV et al. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 2002; 23: 653 – 659.; Das R, Feuerstadt P, Brandt LJ. Glucocorticoids are associated with increased risk of short‐term mortality in hospitalized patients with Clostridium difficile ‐associated disease. Am J Gastroenterol 2010; 105: 2040 – 2049.; Welfare MR, Lalayiannis LC, Martin KE et al. Co‐morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score. J Hosp Infect 2011; 79: 359 – 363.; High KP, Bradley S, Loeb M et al. A new paradigm for clinical investigation of infectious syndromes in older adults: Assessment of functional status as a risk factor and outcome measure. Clin Infect Dis 2005; 40: 114 – 122.; Malani PN, Rana MM, Banerjee M et al. Staphylococcus aureus bloodstream infections: The association between age and mortality and functional status. J Am Geriatr Soc 2008; 56: 1485 – 1489.; Anderson DJ, Chen LF, Schmader KE et al. Poor functional status as a risk factor for surgical site infection due to methicillin‐resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2008; 29: 832 – 839.; Malani PN. Commentary: Debility and the risk for surgical site infection: Defining the next steps. Infect Control Hosp Epidemiol 2008; 29: 840 – 841.; Kyne L, Merry C, O'Connell B et al. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing 1999; 28: 107 – 113.; McDonald LC, Coignard B, Dubberke E et al. Recommendations for surveillance of Clostridium difficile ‐associated disease. Infect Control Hosp Epidemiol 2007; 28: 140 – 145.; Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. Md State Med J 1965; 14: 61 – 65.; Belmares J, Gerding DN, Tillotson G et al. Measuring the severity of Clostridium difficile infection: Implications for management and drug development. Expert Rev Anti Infect Ther 2008; 6: 897 – 908.; Walk ST, Micic D, Jain R et al. Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 2012; 55: 1661 – 1668.; Belmares J, Gerding DN, Parada JP et al. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect 2007; 55: 495 – 501.; Hoste EA, Clermont G, Kersten A et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: A cohort analysis. Crit Care 2006; 10: R73.; Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD‐9‐CM administrative databases. J Clin Epidemiol 1992; 45: 613 – 619.; Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373 – 383.; Delamaire M, Maugendre D, Moreno M et al. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14: 29 – 34.; Knapp S. Diabetes and infection: Is there a link?–A mini‐review. Gerontology 2013; 59: 99 – 104.; Stewart DB, Hollenbeak CS. Clostridium difficile colitis: Factors associated with outcome and assessment of mortality at a national level. J Gastrointest Surg 2011; 15: 1548 – 1555.; Dalton BR, Lye‐Maccannell T, Henderson EA et al. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low‐endemicity, non‐outbreak hospital setting. Aliment Pharmacol Ther 2009; 29: 626 – 634.; Dubberke ER, Reske KA, Olsen MA et al. Short‐ and long‐term attributable costs of Clostridium difficile ‐associated disease in nonsurgical inpatients. Clin Infect Dis 2008; 46: 497 – 504.; McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short‐stay hospitals, 1996–2003. Emerg Infect Dis 2006; 12: 409 – 415.; Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficile ‐related mortality rates, United States, 1999–2004. Emerg Infect Dis 2007; 13: 1417 – 1419.; Burckhardt F, Friedrich A, Beier D et al. Clostridium difficile surveillance trends, Saxony, Germany. Emerg Infect Dis 2008; 14: 691 – 692.; Gravel D, Miller M, Simor A et al. Health care‐associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis 2009; 48: 568 – 576.; Cober ED, Malani PN. Clostridium difficile infection in the “oldest” old: Clinical outcomes in patients aged 80 and older. J Am Geriatr Soc 2009; 57: 659 – 662.; Kuijper EJ, Coignard B, Tüll P et al. Emergence of Clostridium difficile ‐associated disease in North America and Europe. Clin Microbiol Infect 2006; 12: 2 – 18.

الإتاحة: https://doi.org/10.1111/jgs.12442Test
http://hdl.handle.net/2027.42/112304Test

المؤلفون: Rao, Krishna, Walk, Seth T., Micic, Dejan, Chenoweth, Elizabeth, Deng, Lili, Galecki, Andrzej T., Jain, Ruchika, Trivedi, Itishree, Yu, Marie, Santhosh, Kavitha, Ring, Cathrin, Young, Vincent B., Huffnagle, Gary B., Aronoff, David M.

المصدر: PLoS ONE; Mar2013, Vol. 8 Issue 3, p1-7, 7p

مصطلحات موضوعية: CLOSTRIDIOIDES difficile, ETIOLOGY of diseases, BIOMARKERS, BLOOD serum analysis, BLOOD proteins, BIOCHEMISTRY, IMMUNE system, IMMUNOLOGY